Hi I Love Stem Cells community! 👋 After months of deep dives and community listening, we're finally ready to launch two powerful tools we built for you! We’ve been in all the forums, clinics and groups asking where the biggest gaps are in patient care, understanding and transparency. After a lot of conversations, we came out with two tools. The first you already have access to. It’s inside the Classroom now. 👉 The 5-Minute Stem Cell Clinic Vetting Checklist Go check it out here: https://www.skool.com/stemcells/classroom/c727eae1?md=4be793864ea84a859ffc6c366d457284 Take a look and I think you'll see a ton of value in it. The next tool we’re dropping in the coming... stay tuned!

Can someone direct me to the video that was on this group site that address legalities and FDA. It was one of the best videos concerning stem cell facts. I can no longer find it on the site.

The Cell Count Guide is officially available in the Classroom. Learn how many stem cells your body really needs for safe joint therapy, and what red flags to avoid before paying for treatment. 📘 Go to Classroom → “Cell Count Guide” to read or download it. Drop your biggest stem cell question in the comments 👇

🧭 The Real Answer (In Plain English) It’s not that stem cell therapies don’t work — it’s that the U.S. FDA only approves treatments after a long, expensive process designed for pharmaceutical drugs. Most stem cell therapies today (especially MSCs) do not behave like drugs. They’re living cells, which makes them harder to standardize, package, and patent. To get FDA approval, a company must: ✔ Run multi-phase clinical trials (which cost $100M+ and take 7–10 years) ✔ Prove identical results across thousands of patients ✔ Own the therapy under a commercial license Most regenerative therapies are still in Phase I or II trials, meaning the science is strong, but big companies haven’t completed the approval path yet. 🧪 But Here’s the Catch… The science is already strong in areas like: - Osteoarthritis & joint inflammation - Autoimmune regulation - Graft vs Host Disease (approved in Japan & Europe) That’s why other countries (like Mexico, Japan, Panama, South Korea) allow regulated clinical use of MSCs under medical supervision — even while the U.S. waits for pharmaceutical-style approval. 📌 In Short: The U.S. isn’t saying “stem cells don’t work.” It’s saying: “Come back with a drug-level package.” And stem cells are not simple drugs. 🔍 Reference Jayaram, P. et al. (2025). Ethical and Regulatory Considerations Related to Regenerative Medicine. HSS journal: the musculoskeletal journal of Hospital for Special Surgery.

🌎🔥 Let's light up the map! Where's everyone tuning in from? Drop your state below and let's see who's rocking it from coast to coast!👇